Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-29T06:54:07.380Z Has data issue: false hasContentIssue false

Using Microscopy to Qualitatively and Quantitatively Assess Crystalline Content in Amorphous Active Pharmaceutical Ingredients and Drug Product

Published online by Cambridge University Press:  23 September 2015

Andrew D. Vogt
Affiliation:
AbbVie Inc, Drug Product Development, NCE Analytical R&D, North Chicago, ILUSA
Joseph P. Neilly
Affiliation:
AbbVie Inc, Drug Product Development, NCE Analytical R&D, North Chicago, ILUSA

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Abstract
Copyright
Copyright © Microscopy Society of America 2015 

References

[1] Bauer, J., J. Validation Tech (2009). pp. 6368.Google Scholar
[2] Sarsfield, B.A., et al., JCPDS-International Centre for Diffraction Data 2006 ISSN 1097-0002.Google Scholar
[3] Hogan, S & Buckton, G, Pharm Res 18(1) (2001). pp. 112116.CrossRefGoogle Scholar
[4] Solid-State NMR Application Note: Durham University, Solid-State NMR Research Service, 2007.Google Scholar
[5] Zimper, U, et al., Pharmaceutics 2 (2010). pp. 3049.CrossRefGoogle Scholar
[6] Bauer, J, et al., Pharm Res 18(6) (2001). pp. 859866.CrossRefGoogle Scholar
[7] Neilly, J. P., et al., Microsc. Microanal 17(Suppl. 2) (2011) 11301131.CrossRefGoogle Scholar